China accuses GSK of large scale bribery
July 12, 2013Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat
Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …
Publicis Life Brands Resolute appoints account director
July 12, 2013Medical Communications, Sales and Marketing PLBR
Publicis Life Brands Resolute (PLBR) has hired Simon Goldsborough as an account director. Goldsborough brings to the firm over 10 …
MHRA orders recall of Wockhardt drugs after import ban
July 11, 2013Manufacturing and Production MHRA, Wockhardt, recall
The UK regulatory authority has asked for a recall of medicines made at a Wockhardt facility in India, shortly after …
Amgen signs Servier deal
July 11, 2013Sales and Marketing Amgen, Servier, heart, procoloran
Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …
AstraZeneca shores up Cambridge move
July 11, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development
AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …
Tissue Regenix
 appoints non-executive director
July 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing tissue regenix
Regenerative medical devices firm Tissue Regenix has appointed Randeep Singh Grewal as its non-executive
 director of the Group. Grewal has …
NICE no for Celgene’s Revlimid
July 11, 2013Sales and Marketing Celgene, NICE, Revlimid
NICE has issued new draft guidance not recommending Celgene’s bone marrow disorder drug Revlimid over uncertainties of its efficacy. Revlimid …
Pharma chooses Microsoft in drug counterfeit fight
July 10, 2013Medical Communications, Sales and Marketing Microsoft, azure, windows
Microsoft’s Azure cloud platform has been selected to power the new EU-wide European Medicines Verification System (EMVS) that will be …
Blow for Roche as it halts diabetes drug trial
July 10, 2013Research and Development, Sales and Marketing Roche, aleglitazar, diabetes
Roche has stopped a late-stage trial of its investigational diabetes drug aleglitazar over safety concerns. The move was prompted by …
Court overturns orphan refusal
July 10, 2013Sales and Marketing EMA, laboratoires ctrs, orphacol
A European Commission decision last year to refuse marketing authorisation for an orphan drug has been overturned by a major …
Fresenius Kabi hit by second FDA warning letter
July 10, 2013Manufacturing and Production API, FDA, Fresenius Kabi, GMP
German generic drugmaker Fresenius Kabi has been sent another warning letter from the FDA citing deficiencies at a manufacturing plant. …
Say Communications hires associate director
July 10, 2013Medical Communications, Research and Development, Sales and Marketing chicco, say
Health PR firm Say Communications has announced the appointment of Victoria Bramham as an associate director to help lead its …
GSK files cancer combination
July 10, 2013Sales and Marketing FDA, GSK, Tafinlar, mekinist
GlaxoSmithKline has put in supplemental applications for its Tafinlar/Mekinist combination – a pair of drugs which analysts predict may have …
Novartis compound beats Enbrel
July 9, 2013Sales and Marketing Enbrel, Novartis, Pfizer, skin
One of Novartis’ investigational drugs has beaten Pfizer’s Enbrel in a head-to-head Phase III psoriasis study and is on course …
GSK teams up with Oxford biotech on cancer
July 9, 2013Research and Development, Sales and Marketing GSK, Oxford, immunocore
GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …
Pharma chemicals added to EU pollutant watch list
July 9, 2013Manufacturing and Production EFPIA, EU, WFD, pollutants
For the first time, three pharmaceutical compounds – two hormones and an anti-inflammatory drug – will be included in a …
Pharma views sought on UK regulation
July 9, 2013Research and Development, Sales and Marketing ABPI, MHRA, pharma
A new review is inviting pharma to tell the UK government just how well national regulators and local authorities enforce …
Continuum appoints new president
July 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing continuum health alliance, olivia
Healthcare management firm Continuum Health Alliance has appointed Christopher Olivia to be the president of the company.Dr Olivia will help lead Continuum into …
MSD takes Januvia rap
July 9, 2013Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA
Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …
GSK China probe extends to Botox sales
July 8, 2013Sales and Marketing Botox, China, GSK, whistleblower
GlaxoSmithKline’s woes in China are continuing as the firm’s sales tactics with Botox are put under scrutiny. The London-based firm …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
